المصدر: A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (Age 12 Years to < 18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06253221Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.bmsstudyconnect.com/content/studyconnect/us/en/clinical-trials/NCT06253221.htmlTest

المصدر: MEMENTO - A Phase 3b/4, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure With Cardiac Magnetic Resonance Imaging (CMR)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06112743Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.bmsstudyconnect.com/content/studyconnect/us/en/clinical-trials/NCT06112743.htmlTest

المصدر: A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05582395Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.bmsstudyconnect.com/content/studyconnect/us/en/clinical-trials/NCT05582395.htmlTest

المصدر: A Phase 2a, Open-label, Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction (MERCUTIO)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05556343Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.bmsstudyconnect.com/content/studyconnect/us/en/clinical-trials/NCT05556343.htmlTest

المصدر: A Phase 3, Open-label, Single Arm, Clinical Study to Evaluate Efficacy, Safety and Tolerability of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05414175Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.BMSStudyConnect.comTest
https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htmTest

المصدر: mavaCamten ObservationaL evIdence Global cOnsortium in HCM (COLLIGO-HCM)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06372457Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alertsTest

المصدر: Real-World Effectiveness of MAVacamtEN in Canada (MAVEN): A Retrospective Physician Survey of Patient Charts

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06338202Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alertsTest

المصدر: Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06181617Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alertsTest

المصدر: CAMZYOS® (Mavacamten) Post-Marketing Surveillance in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06146660Test

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research.htmlTest
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alertsTest

المصدر: Mavacamten Pregnancy Surveillance Program

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05939700Test